Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing carvedilol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carvedilol (substance) |
Inferred relationship |
Some |
1 |
Carvedilol adverse reaction |
Causative agent (attribute) |
True |
Carvedilol (substance) |
Inferred relationship |
Some |
1 |
Allergy to carvedilol (finding) |
Causative agent (attribute) |
False |
Carvedilol (substance) |
Inferred relationship |
Some |
|
Carvedilol 12.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carvedilol (substance) |
Inferred relationship |
Some |
|
Carvedilol 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carvedilol (substance) |
Inferred relationship |
Some |
|
Carvedilol 3.125 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carvedilol (substance) |
Inferred relationship |
Some |
|
Carvedilol 6.25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carvedilol (substance) |
Inferred relationship |
Some |
|
Carvedilol 10mg controlled release capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carvedilol (substance) |
Inferred relationship |
Some |
|
Carvedilol 20mg controlled release capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carvedilol (substance) |
Inferred relationship |
Some |
|
Carvedilol 40mg controlled release capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carvedilol (substance) |
Inferred relationship |
Some |
|
Carvedilol 80mg controlled release capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carvedilol (substance) |
Inferred relationship |
Some |
|
Carvedilol phosphate (substance) |
Is a |
False |
Carvedilol (substance) |
Inferred relationship |
Some |
|
Allergy to carvedilol (finding) |
Causative agent (attribute) |
True |
Carvedilol (substance) |
Inferred relationship |
Some |
1 |
Carvedilol therapy (procedure) |
Direct substance |
True |
Carvedilol (substance) |
Inferred relationship |
Some |
2 |
Carvedilol 12.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carvedilol (substance) |
Inferred relationship |
Some |
1 |
Carvedilol 12.5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Carvedilol (substance) |
Inferred relationship |
Some |
1 |
Carvedilol 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carvedilol (substance) |
Inferred relationship |
Some |
1 |
Carvedilol 25 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Carvedilol (substance) |
Inferred relationship |
Some |
1 |
Carvedilol 3.125 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carvedilol (substance) |
Inferred relationship |
Some |
1 |
Carvedilol 3.125 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Carvedilol (substance) |
Inferred relationship |
Some |
1 |
Carvedilol 6.25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carvedilol (substance) |
Inferred relationship |
Some |
1 |
Carvedilol 6.25 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Carvedilol (substance) |
Inferred relationship |
Some |
1 |
Administration of carvedilol (procedure) |
Direct substance |
True |
Carvedilol (substance) |
Inferred relationship |
Some |
1 |
Carvedilol phosphate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Carvedilol (substance) |
Inferred relationship |
Some |
|
Carvedilol 12.5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Carvedilol (substance) |
Inferred relationship |
Some |
1 |
Carvedilol 25 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Carvedilol (substance) |
Inferred relationship |
Some |
1 |
Carvedilol 3.125 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Carvedilol (substance) |
Inferred relationship |
Some |
1 |
Carvedilol 6.25 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Carvedilol (substance) |
Inferred relationship |
Some |
1 |
Carvedilol-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carvedilol (substance) |
Inferred relationship |
Some |
1 |
Carvedilol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carvedilol (substance) |
Inferred relationship |
Some |
1 |
Product containing only carvedilol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carvedilol (substance) |
Inferred relationship |
Some |
1 |